Demir, Rumeysa https://orcid.org/0000-0003-2296-1569
Inangil, Demet https://orcid.org/0000-0002-5389-5691
Turkoglu, Ilayda https://orcid.org/0000-0002-2382-6257
Sendir, Merdiye https://orcid.org/0000-0002-8243-1669
Article History
Received: 29 August 2025
Accepted: 30 December 2025
First Online: 6 January 2026
Declarations
:
: Ethical approval for this study was obtained from the Non-Interventional Clinical Research Ethics Committee of Istanbul Medipol University (E-10840098-772.02–1639/205). Also, the patients participating in the study were informed about the study and their verbal and written informed consents were obtained. Verbal and written informed consent was provided by all the nurses who participated in the study. Each stage of the study was carried out on a voluntary basis. The study was conducted in accordance with the Declaration of Helsinki. Permission was obtained from the developer of the subcutaneous insulin administration form. Before starting the study, ethical principles were taken into consideration according to the clinical trial number (Date:21.07.2022/NCT05469035).
: Not applicable.
: The authors declare no competing interests.